Jul 16, 2018 - Hochman Cole Investment Advisors, Inc. Buys First Trust Technology AlphaDEX, VanEck Vectors Morningstar Wide Moat, First Trust Health Care AlphaDEX, Sells Vanguard Short-Term Bond, Invesco Aerospace & Defense, First Trust Energy Income & Growth Fund, Stocks: CELG,PFE,FXL,MOAT,FXH,IYE,JPM,LMBS,BSV,PPA,PWC,, release date:Jul 16, 2018
Jul 16, 2018 - Some drug companies continue to raise prices, despite mounting public scrutiny and pressure from the president, a move one analyst says "makes no sense."
Jul 16, 2018 - Mcrae Capital Management Inc Buys Wyndham Hotels & Resorts Inc, Procter & Gamble Co, Wyndham Destinations Inc, Sells Barings Global Short Duration High Yield Fund, Bristol-Myers Squibb Company, JM Smucker Co, Stocks: PG,PFE,TPR,T,AMGN,HD,WH,WYND,FDX,NVT,ICE,TXN,BMY,W, release date:Jul 16, 2018
Jul 16, 2018 - Array's melanoma combo gets a guideline nod. Atossa looks for a window of opportunity in breast cancer. Astellas and Pfizer score widened approval for Xtandi.
Jul 16, 2018 - Most investors invest to get rich, which we all define differently.For most, it means at the very least, achieving a comfortable retirement, while for myself, it means becoming financially independent
Jul 16, 2018 - Pfizer Inc. said Monday it has started late-stage clinical testing of an experimental gene therapy treatment, originally developed by Spark Therapeutics in Philadelphia, for patients with hemophilia B.
The transfer of the gene therapy program to Pfizer from Spark is now complete, the companies said.
Under the terms of a product license agreement signed in December 2014, Pfizer has now assumed sole responsibility for all subsequent pivotal studies, all regulatory activities, manufacturing and global…
Jul 16, 2018 - Aquestive Therapeutics has filed amended terms for its $60 million U.S. IPO.The firm combines a manufacturing operation with a more recent development pipeline.AQST is pursuing an intriguing business
Jul 16, 2018 - I have been working on my Millennial Portfolio for almost two years and have picked out 22 stocks so far.The portfolio is growth-oriented but also contains safer, low-growth stocks because I fear a be
Jul 16, 2018 - The drugmaker's second reorganization in four years signals where the company is headed. But it doesn't solve its most serious problem.
Jul 16, 2018 - FDA approves Pfizer's (PFE) sNDA to expand the label of Xtandi to include the non-metastatic prostate cancer patient population.